Precision BioSciences Revenue and Competitors
Estimated Revenue & Valuation
- Precision BioSciences's estimated annual revenue is currently $118M per year.
- Precision BioSciences received $40.0M in venture funding in March 2019.
- Precision BioSciences's estimated revenue per employee is $786,933
- Precision BioSciences's total funding is $175.2M.
- Precision BioSciences's current valuation is $361M. (January 2022)
Employee Data
- Precision BioSciences has 150 Employees.
- Precision BioSciences grew their employee count by -39% last year.
Precision BioSciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief People Officer, Precision BioSciences | Reveal Email/Phone |
2 | SVP Chemistry, Manufacturing, and Controls (CMC) | Reveal Email/Phone |
3 | VP, Operations and Information Technology | Reveal Email/Phone |
4 | Head Supply & Operations Planning | Reveal Email/Phone |
5 | General Counsel | Reveal Email/Phone |
6 | VP, Intellectual Property | Reveal Email/Phone |
7 | VP, Research Operations | Reveal Email/Phone |
8 | SVP Human Resources | Reveal Email/Phone |
9 | VP, Genomcs | Reveal Email/Phone |
10 | VP, Gene Therapy Discovery | Reveal Email/Phone |
Precision BioSciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Precision BioSciences?
Precision BioSciences is a privately held biotechnology company dedicated to improving lives through its next generation gene editing technology, ARCUS. Precision's cell therapy, gene therapy, and agriculture programs are based on the proprietary ARC endonuclease, which features coordinated target site binding and DNA cutting to ensure precise edits. Our team includes pioneers in genome engineering, biotech business leaders, and a staff of committed Precisioneers. We work together in our beautifully designed, award-winning space in vibrant downtown Durham, NC; a place with great restaurants and museums as well as fantastic housing and schools. Precision provides all employees a sense of purpose, thoughtfully designed laboratory and office spaces, and opportunities to train and grow not to mention plentifully stocked kitchens and benefits like wellness massage. At Precision BioSciences, we are excited to work together toward improving lives by realizing the potential of gene editing.
keywords:Biotechnology,Cleantech,Food & Beverages,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power$175.2M
Total Funding
150
Number of Employees
$118M
Revenue (est)
-39%
Employee Growth %
$361M
Valuation
N/A
Accelerator
Precision BioSciences News
Precision BioSciences Inc gets a 72 rank in the Biotechnology industry. Biotechnology is number 74 out of 148 industries. Overall Score - 51.
Precision BioSciences, Inc, a clinical stage gene editing company, develops vivo gene editing and ex vivo allogeneic CAR T therapies in the...
That average rating earns Precision BioSciences Inc an Analyst Ranking of 59, which means it ranks higher than 59 of stocks, based on data...
DURHAM, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (DTIL) (“Precision”), a genome editing company dedicated ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 151 | 6% | N/A |
#2 | $21.7M | 152 | -3% | N/A |
#3 | $50.2M | 152 | 9% | N/A |
#4 | $26.9M | 153 | -1% | N/A |
#5 | $31M | 154 | 56% | N/A |
Precision BioSciences Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2015-05-12 | $25.6M | A | venBio | Article |
2018-06-11 | $88.1M | Undisclosed | Article | |
2018-06-27 | $110.0M | Undisclosed | ArrowMark Partners | Article |
2019-03-12 | $40.0M | Undisclosed | Mulitple | Article |